Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gennaro Musi

Showing results (61-70 of 265) with videos related to

Pageof 27
Sort By:
Urologic Oncology|March 7, 2020
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysisStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
World Journal of Urology|January 22, 2020
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladderStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Journal of Endourology|March 18, 2020
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate CancerStefano Luzzago, Giuseppe Rosiello, Angela Pecoraro, et al.
Surgical Oncology|January 5, 2021
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancerStefano Luzzago, Giuseppe Rosiello, Angela Pecoraro, et al.
American Journal of Clinical Oncology|May 30, 2020
The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary BladderStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Urologic Oncology|July 28, 2022
Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinomaClaudia Collà Ruvolo, Marina Deuker, Mike Wenzel, et al.
Cancers|May 13, 2020
Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral CenterGiovanni Mauri, Francesco Alessandro Mistretta, Guido Bonomo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 16, 2020
Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomesFrancesco A Mistretta, Cristina Negrean-Dzyuba, Carlotta Palumbo, et al.
European Urology Focus|May 24, 2020
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma PatientsStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Urologia Internationalis|May 8, 2018
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance ProtocolStefano Luzzago, Gennaro Musi, Michele Catellani, et al.
Pageof 27

Showing results (61-70 of 265) with videos related to

Sort By:
Pageof 27
Urologic Oncology|March 7, 2020
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysisStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
World Journal of Urology|January 22, 2020
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladderStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Journal of Endourology|March 18, 2020
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate CancerStefano Luzzago, Giuseppe Rosiello, Angela Pecoraro, et al.
Surgical Oncology|January 5, 2021
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancerStefano Luzzago, Giuseppe Rosiello, Angela Pecoraro, et al.
American Journal of Clinical Oncology|May 30, 2020
The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary BladderStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Urologic Oncology|July 28, 2022
Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinomaClaudia Collà Ruvolo, Marina Deuker, Mike Wenzel, et al.
Cancers|May 13, 2020
Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral CenterGiovanni Mauri, Francesco Alessandro Mistretta, Guido Bonomo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 16, 2020
Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomesFrancesco A Mistretta, Cristina Negrean-Dzyuba, Carlotta Palumbo, et al.
European Urology Focus|May 24, 2020
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma PatientsStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Urologia Internationalis|May 8, 2018
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance ProtocolStefano Luzzago, Gennaro Musi, Michele Catellani, et al.
Pageof 27